GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in healthcare investigation, largely due to its impressive impact on managing conditions such as type 2 diabetes and excess body fat. Ongoing research have revealed that beyond glucose regulation,